Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer
Titel:
Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer
Auteur:
Chick, R. Connor Clifton, G. Travis Hale, Diane F. Vreeland, Timothy J. Hickerson, Annelies T. Kemp Bohan, Phillip M. McCarthy, Patrick M. Litton, Jennifer K. Alatrash, Gheath Murthy, Rashmi K. Qiao, Na Philips, Anne Lukas, Jason Holmes, Jarrod P. Mittendorf, Elizabeth A. Peoples, George E.